Skip to content

Pharmacy

NACDS promotes six to advance Access Agenda

NACDS promotes six to advance Access Agenda

ARLINGTON, Va. – The National Association of Chain Drug Stores  has promoted six staff members to roles vital to the advancement of the NACDS Access Agenda and its related issue campaigns. Michael Angeloni was named government affairs and communications associate.

Global Rx spending forecast to exceed $1.5 trillion by 2023

Global Rx spending forecast to exceed $1.5 trillion by 2023

The global pharmaceutical market is expected to grow at a slower rate over the next five years, according to a new report released Tuesday from IQVIA. Global spending on medicine reached $1.2 trillion in 2018, according to the report, and by 2023, that number could exceed $1.5 trillion.

Kroger Health, PTS Diagnostics launch CardioChek Plus analyzers

Kroger Health, PTS Diagnostics launch CardioChek Plus analyzers

PTS Diagnostics and Kroger Health, Kroger Co.’s nationwide arm of health and wellness facilities, services and programs, announce the full rollout of CardioChek Plus analyzers for point-of-care blood testing to help identify individuals at-risk of heart attack, stroke and diabetes.

NACDS gives input on HHS’ Healthy People 2030 initiative

NACDS gives input on HHS’ Healthy People 2030 initiative

The National Association of Chain Drug Stores (NACDS) has submitted comments containing recommendations for the Department of Health and Human Services’ (HHS) Healthy People 2030 initiative, which develops a new set of evidence-based, 10-year national objectives aimed at improving the health of all

ACPE elects new officers, announces new board members

ACPE elects new officers, announces new board members

CHICAGO – The Accreditation Council for Pharmacy Education (ACPE) announced that Lori Duke, Anthony Provenzano, and Michael Moné have been elected as members of the ACPE executive committee for the 2019–2020 term of office.

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s Laboratories and its subsidiary, Promius Pharma. today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration (FDA). Tosymra is indicated for the acute treatment of migraine with or without aura in adults.

NACDS demonstrates need for DIR fee reform in comments to CMS

NACDS demonstrates need for DIR fee reform in comments to CMS

Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented comments to the Centers for Medicare & Medicaid Services in support of the agency’s proposal to refor